Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: PDX model of advanced cutaneous squamous cell carcinoma

PROVIDER: PRJDB15107 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR438367_1.fastq.gz	Fastqsanger.gz
	DRR438367_2.fastq.gz	Fastqsanger.gz
	DRR438368_1.fastq.gz	Fastqsanger.gz
	DRR438368_2.fastq.gz	Fastqsanger.gz
	DRR438369_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Homo sapiens

Project description:Sequencing Analysis of Cutaneous Squamous Cell Carcinoma

| PRJNA259587 | ENA

Homo sapiens

Project description:MicroRNA Expression in Cutaneous Squamous Cell Carcinoma

| PRJNA248044 | ENA

Homo sapiens

Project description:circRNA expression in cutaneous squamous cell carcinoma (cSCC)

| PRJNA301432 | ENA

Homo sapiens

Project description:Long non-coding RNAs in cutaneous squamous cell carcinoma

| PRJNA301689 | ENA

Homo sapiens

Project description:Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma

| PRJNA151387 | ENA

Expression analysis of gene expression chang in Homo sapiens Esophageal squamous cell carcinoma cells KYSE30 after knock down MTA2 gene

Project description:Investigation of whole genome gene expression level changes in Homo sapiens Esophageal squamous cell carcinoma cells KYSE30 after knock down of MTA2 gene expression

2021-03-10 | GSE112495 | GEO

Homo sapiens

Project description:Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma

| PRJNA393854 | ENA

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

Project description:This is a Phase 1b/2, open-label multicenter study evaluating NKTR-255 as a monotherapy and together with cetuximab in patients with head and neck squamous cell carcinoma (HNSCC), colorectal carcinoma (CRC), cutaneous squamous cell carcinoma (cSCC), anal cell carcinoma (ASCC) and cervical cancer. The recommended phase 2 dose of NKTR-255, determined in the dose escalation phase (Phase 1b), will be used to treat patients in Phase 2 of this study.

| 2356733 | ecrin-mdr-crc

COL11A1 mutations in cutaneous squamous cell carcinoma [WES]

Project description:Whole exome sequencing was used to identify frequent COL11A1 mutations in cutaneous squamous cell carcinoma (cSCC).

2021-07-23 | GSE179296 | GEO

Project description:Cutaneous squamous cell carcinoma (cSCC) transcriptomes

| PRJNA844527 | ENA